Skip to main content
. 2017 Jan 5;41(3):386–391. doi: 10.1016/j.jgr.2016.11.001

Fig. 4.

Fig. 4

In vivo antitumorigenic effects of WE, NSF, and SF in xenograft mice. (A) Schedule for evaluating the antitumorigenic effects of WE, NSF, and SF in a mouse xenograft mouse model. Mice were subcutaneously injected with 10,000 CT-26 cells in a volume of 0.1 mL. (B) Tumors volumes were determined using digital calipers every 3 d for 18 d. (C) Body weight was measured every 3 d for 18 d. *p < 0.05, **p < 0.01 compared with control cells.